Indication
Psoriasis
The Psoriasis pipeline: 69 tracked drugs, 24 approved for this indication.
24 approved / phase 418 Phase 33 Phase 2/319 Phase 21 Phase 1/24 Phase 1
Compare the share prices of listed companies in Psoriasis →
Total attributable cost
$87.4B
$11,062/patient
Drug spend
Not yet sourced
All severities, physician-diagnosed history (2023 NHIS) · US